Healthcare News

RayClinic har i dagarna träffat avtal med byggentrepenören PEAB för att bygga den första privata strålbehandlingskliniken i Sverige. Avtalet innebär att PEAB är generalentrepenör och har åtagit sig...

Novo Nordisk today announced a decision to focus all its research and development (R&D) resources on the company's growing pipeline of protein-based pharmaceuticals. As a result of this decision the...

Novo Nordisk meddeler i dag, at det er besluttet at koncentrere alle forsknings- og udviklingsressourcer om virksomhedens voksende portefølje af proteinbaserede lægemidler. Som følge af denne...

Novo Nordisk today announced a decision to focus all its research and development (R&D) resources on the company's growing pipeline of protein-based pharmaceuticals. As a result of this decision...

Orion Corporation (OMX: ORNAV, ORNBV) will publish its official 2006 Financial Statements as well as proforma information carved out from the demerged Orion's financial statements  on Tuesday, 6...

Orion tiedottaa vuoden 2006 tilinpäätöksestään tiistaina 6. helmikuuta 2007. Arvioitu julkaisuaika on klo 12. Virallisen tilinpäätöksen kaudelta 1.7.- 31.12.2006 lisäksi annetaan proformatietoja,...

NEW YORK, Jan. 12, 2007 (PRIME NEWSWIRE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) previously reported in its Form 10-QSB for the quarter ended September 30, 2006 that at September 30, 2006, the...

NEW YORK, Jan. 12, 2007 (PRIME NEWSWIRE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and World Health Energy, Inc. announced that the company will be utilizing a more efficient biodiesel...

Today, Cipralex® (escitalopram) has been approved in the EU for the treatment of obsessive compulsive disorder (OCD) by the Swedish Medical Products Agency (MPA) acting as reference member state for...

Cipralex® (escitalopram) er i dag blevet godkendt i EU til behandling af obsessiv-kompulsiv sygdom (OCD) af sundhedsmyndighederne i Sverige, som fungerer som referencemedlemsland for den Europæiske...